Martingale Asset Management L P Morphic Holding, Inc. Transaction History

Martingale Asset Management L P

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$19.74 - $43.01 $235,024 - $512,077	-11,906 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$43.27 - $65.72 $47,597 - $72,292	-1,100 Reduced 8.46%	11,906 $564,000
Q3 2021 Nov 12, 2021	BUY	$53.61 - $67.5 $697,251 - $877,905	13,006 New	13,006 $736,000
Q2 2021 Aug 13, 2021	SELL	$45.13 - $64.99 $280,076 - $403,327	-6,206 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$29.77 - $84.85 $184,752 - $526,579	6,206 New	6,206 $392,000

142

37.9M

13.5K

190K

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.